Shop the future of skin longevity: Dr Sebagh launches exosome-powered skincare
Dr Jean-Louis Sebagh is expanding his regenerative skincare offering with the introduction of injectable autologous exosome treatments in his London and Paris clinics, alongside the launch of Exo C Booster, the first product in his skincare range to feature plant-derived exosome technology.The announcement comes as Dr Sebagh also launches his Summer Professional Size Sale, giving customers the opportunity to upgrade to professional-size products at no extra cost.With more than 40 years at the forefront of aesthetic medicine, Dr Sebagh has built a reputation for treatments that focus on maintaining healthy, resilient skin rather than dramatic transformation.
His latest developments continue that philosophy, introducing regenerative science that supports the skin’s natural repair processes both in the clinic and at home.Exosomes are microscopic extracellular vesicles that enable communication between cells, carrying growth factors, microRNAs and other bioactive molecules that encourage repair and regeneration.Their role in regenerative medicine has attracted growing attention for their ability to improve skin quality, stimulate collagen production and support recovery.At Dr Sebagh’s London and Paris clinics, patients can now access injectable autologous exosome treatments as part of a medically supervised program.
Using the certified Meta Cell Technology (MCT) System, exosomes are extracted from the patient’s own blood before being processed through photothermal biomodulation and reintroduced into the skin.Because the treatment uses the patient’s own biology, there is no risk of immune rejection or the need for external additives.The treatment is designed to promote cellular regeneration, encourage collagen and elastin production, reduce inflammation, support tissue repair and accelerate recovery following aesthetic procedures.
It can also complement Dr Sebagh’s established treatment portfolio.Alongside the clinical treatment, Dr Sebagh has introduced Exo...